Life Sciences Queensland (LSQ) is proud to announce that we are co-hosting the upcoming Contamination Control & Quality Risk Management conference with ISPE Australasia. As the life sciences sector faces evolving regulations and increasingly complex manufacturing processes, the need for robust quality systems has never been greater.
Ahead of this premier event in February 2026, we are exploring why Contamination Control Strategies and Quality Risk Management are moving to the forefront of industry conversation.
Beyond the Checklist: The Evolution of Contamination Control
For years, contamination control was often viewed as a series of isolated checks: monitoring air quality here, swabbing a surface there. However, modern Good Manufacturing Practice (GMP) demands a shift from reactive monitoring to proactive strategy.
As highlighted in recent industry discussions, including the PDA’s analysis of Contamination Control Strategies, a true CCS is not merely a document to satisfy an auditor. It is instead a holistic philosophy. It requires a deep understanding of the entire manufacturing process, from raw materials to the final patient. By mapping out every potential point of entry for contaminants, manufacturers can design processes that ensure quality by design rather than testing for it at the end.
Integrating Risk into the Quality Management System
A successful strategy also requires breaking down silos. Too often, critical data remains locked in the microbiology lab, disconnected from the broader quality assurance teams.
In "Contamination Control, Risk and the Quality Management System," the pharmaceutical industry blog Investigations of a Dog argues for getting microbiologists out of the lab and integrating them into the heart of the Quality Management System. By using a risk-based approach, often visualised through tools like the "House of Quality", organisations can ensure that contamination control is a living part of their daily operations, driving continuous improvement rather than static compliance.
Join Us to Drive the Mission Forward
This alignment of technical expertise and regulatory compliance is at the core of ISPE’s mission: to lead scientific, technical, and regulatory advancement throughout the entire pharmaceutical lifecycle.
The upcoming ISPE Australasia & LSQ Contamination Control & Quality Risk Management event (17–19 February 2026) is your opportunity to see these concepts in action. With sessions led by TGA & APVMA regulators, international experts, and industry leaders (plus exclusive site tours of the TRI precinct) this is an unmissable event for professionals dedicated to the production of safe, quality medicines.
